AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE

AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE was reported 149 times

These side effects are most commonly reported by patients taking AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE:

# Side effect Count
0 RASH 15
1 ERYTHEMA 12
2 ACNE 10
3 DRY SKIN 10
4 SUNBURN 9
5 MALIGNANT MELANOMA 8
6 OFF LABEL USE 8
7 CONDITION AGGRAVATED 7
8 DERMATITIS 7
9 DIARRHOEA 7
10 HEADACHE 7
11 APPLICATION SITE ERYTHEMA 6
12 DRUG INEFFECTIVE 6
13 FATIGUE 6
14 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
15 PAIN 6
16 PHOTOSENSITIVITY REACTION 6
17 SKIN EXFOLIATION 6
18 SWELLING FACE 6
19 ARTHRALGIA 5
20 BLISTER 5
21 DEPRESSION 5
22 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
23 PRODUCT USE ISSUE 5
24 PRURITUS 5
25 PSORIASIS 5
26 SKIN BURNING SENSATION 5
27 XEROSIS 5
28 APPLICATION SITE PAIN 4
29 BASAL CELL CARCINOMA 4
30 DRUG HYPERSENSITIVITY 4
31 DRY EYE 4
32 ECZEMA 4
33 HYPERSENSITIVITY 4
34 MALAISE 4
35 PAIN OF SKIN 4
36 PIGMENTATION DISORDER 4
37 RASH ERYTHEMATOUS 4
38 SKIN HYPERPIGMENTATION 4
39 SOMNOLENCE 4
40 THERAPEUTIC RESPONSE UNEXPECTED 4
41 ANXIETY 3
42 ASTHENIA 3
43 BURNING SENSATION 3
44 CHEILITIS 3
45 COUGH 3
46 HEART RATE INCREASED 3
47 HOSPITALISATION 3
48 ILLNESS 3
49 INTENTIONAL PRODUCT MISUSE 3
50 MOOD ALTERED 3
51 MUSCULOSKELETAL STIFFNESS 3
52 NAUSEA 3
53 OVERDOSE 3
54 PAIN IN EXTREMITY 3
55 PRODUCT DOSE OMISSION ISSUE 3
56 SENSITIVE SKIN 3
57 SKIN DISCOLOURATION 3
58 SKIN IRRITATION 3
59 SYSTEMIC LUPUS ERYTHEMATOSUS 3
60 UNDERDOSE 3
61 URTICARIA 3
62 WEIGHT DECREASED 3
63 ABDOMINAL DISCOMFORT 2
64 ABDOMINAL PAIN UPPER 2
65 ABNORMAL LOSS OF WEIGHT 2
66 ACNE CYSTIC 2
67 ADVERSE EVENT 2
68 APPLICATION SITE DISCHARGE 2
69 APPLICATION SITE DISCOLOURATION 2
70 APPLICATION SITE EXFOLIATION 2
71 BACK PAIN 2
72 CHOLECYSTITIS ACUTE 2
73 CHOLESTASIS 2
74 CONTUSION 2
75 DEATH 2
76 DECREASED APPETITE 2
77 DISCOMFORT 2
78 DRUG INTOLERANCE 2
79 DRY MOUTH 2
80 DYSPHAGIA 2
81 DYSPNOEA 2
82 EYE IRRITATION 2
83 EYE PAIN 2
84 FALL 2
85 GASTROINTESTINAL HAEMORRHAGE 2
86 HYPERHIDROSIS 2
87 IMMUNE SYSTEM DISORDER 2
88 IMMUNE-MEDIATED HEPATITIS 2
89 INFECTION 2
90 INFLAMMATION 2
91 INTENTIONAL PRODUCT USE ISSUE 2
92 INTENTIONAL UNDERDOSE 2
93 JOINT SWELLING 2
94 LENTIGO 2
95 LUNG NEOPLASM MALIGNANT 2
96 MELANOCYTIC NAEVUS 2
97 MILIARIA 2
98 MIOSIS 2
99 MUSCLE SPASMS 2
100 MYALGIA 2
101 PERIPHERAL SWELLING 2
102 PNEUMONIA 2
103 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
104 PRODUCT QUALITY ISSUE 2
105 PSORIATIC ARTHROPATHY 2
106 PYREXIA 2
107 RASH MACULAR 2
108 RASH PAPULAR 2
109 SEBORRHOEIC KERATOSIS 2
110 SEIZURE 2
111 SKIN HAEMORRHAGE 2
112 SKIN LESION 2
113 SKIN WARM 2
114 SQUAMOUS CELL CARCINOMA 2
115 SWELLING 2
116 TACHYCARDIA 2
117 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
118 ABDOMINAL DISTENSION 1
119 ABDOMINAL PAIN 1
120 ACCIDENTAL EXPOSURE TO PRODUCT 1
121 ACTINIC KERATOSIS 1
122 ACUTE KIDNEY INJURY 1
123 ACUTE PULMONARY OEDEMA 1
124 ADDISON^S DISEASE 1
125 ALANINE AMINOTRANSFERASE INCREASED 1
126 ALOPECIA 1
127 AMMONIA INCREASED 1
128 ANAEMIA 1
129 ANAL FISTULA 1
130 ANGIOPATHY 1
131 APPLICATION SITE HAEMORRHAGE 1
132 APPLICATION SITE IRRITATION 1
133 APPLICATION SITE NODULE 1
134 APPLICATION SITE PRURITUS 1
135 APPLICATION SITE RASH 1
136 APPLICATION SITE SCAB 1
137 APPLICATION SITE SWELLING 1
138 APPLICATION SITE VESICLES 1
139 ARTHROPOD STING 1
140 ASCITES 1
141 ASPARTATE AMINOTRANSFERASE INCREASED 1
142 ASPIRATION 1
143 ASTHMA 1
144 ATRIAL FIBRILLATION 1
145 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1
146 BACK DISORDER 1
147 BACTERIAL INFECTION 1
148 BALANCE DISORDER 1
149 BLOOD CALCIUM INCREASED 1
150 BLOOD CHOLESTEROL INCREASED 1
151 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
152 BLOOD GLUCOSE INCREASED 1
153 BLOOD PRESSURE DECREASED 1
154 BLOOD PRESSURE INCREASED 1
155 BRONCHOSPASM 1
156 C-REACTIVE PROTEIN 1
157 CARDIAC MURMUR 1
158 CARDIOMEGALY 1
159 CATARACT OPERATION 1
160 CATARRH 1
161 CEREBROVASCULAR ACCIDENT 1
162 CHEMICAL BURN 1
163 CHEMICAL BURNS OF EYE 1
164 CHEST PAIN 1
165 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
166 CONFUSIONAL STATE 1
167 CONJUNCTIVITIS ALLERGIC 1
168 CONSTIPATION 1
169 CONTRAINDICATED PRODUCT ADMINISTERED 1
170 CONVULSION 1
171 COVID-19 1
172 DEHYDRATION 1
173 DERMATITIS CONTACT 1
174 DERMATITIS PSORIASIFORM 1
175 DIABETES MELLITUS 1
176 DISABILITY 1
177 DISEASE PROGRESSION 1
178 DISEASE RECURRENCE 1
179 DROOLING 1
180 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
181 DRUG EFFECT INCOMPLETE 1
182 DRUG EFFECT LESS THAN EXPECTED 1
183 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
184 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
185 DYSPEPSIA 1
186 DYSPNOEA EXERTIONAL 1
187 ENCEPHALITIS 1
188 ENDOMETRIOSIS 1
189 EPISTAXIS 1
190 EXPIRED PRODUCT ADMINISTERED 1
191 EXPOSURE TO MOULD 1
192 EYE OEDEMA 1
193 FACIAL ASYMMETRY 1
194 FEELING HOT 1
195 FLATULENCE 1
196 FLUSHING 1
197 FREQUENT BOWEL MOVEMENTS 1
198 FUNGAL OESOPHAGITIS 1
199 GAIT DISTURBANCE 1
200 GASTRIC ULCER 1
201 GASTROENTERITIS VIRAL 1
202 GASTROINTESTINAL DISORDER 1
203 GASTROINTESTINAL MELANOSIS 1
204 GENERAL PHYSICAL HEALTH DETERIORATION 1
205 GENERALISED ERYTHEMA 1
206 GLOSSODYNIA 1
207 GUTTATE PSORIASIS 1
208 HAEMANGIOMA 1
209 HAEMATURIA 1
210 HAEMORRHAGE 1
211 HAIR COLOUR CHANGES 1
212 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1
213 HEPATITIS 1
214 HOT FLUSH 1
215 HYPERAESTHESIA 1
216 HYPEREOSINOPHILIC SYNDROME 1
217 HYPERGLYCAEMIA 1
218 HYPERKERATOSIS 1
219 HYPERSOMNIA 1
220 HYPERTENSION 1
221 HYPERTRIGLYCERIDAEMIA 1
222 HYPOPHAGIA 1
223 HYPOTENSION 1
224 IMMUNOSUPPRESSION 1
225 INCORRECT DOSAGE ADMINISTERED 1
226 INCORRECT DRUG ADMINISTRATION DURATION 1
227 INCORRECT PRODUCT ADMINISTRATION DURATION 1
228 INCORRECT PRODUCT STORAGE 1
229 INFLUENZA 1
230 INFLUENZA LIKE ILLNESS 1
231 INJECTION SITE DRYNESS 1
232 INJECTION SITE HAEMORRHAGE 1
233 INJECTION SITE MASS 1
234 INJECTION SITE PAIN 1
235 INJECTION SITE PRURITUS 1
236 INJECTION SITE REACTION 1
237 INJECTION SITE SWELLING 1
238 INJURY ASSOCIATED WITH DEVICE 1
239 INSOMNIA 1
240 INTENTIONAL DOSE OMISSION 1
241 JAUNDICE 1
242 JOINT STIFFNESS 1
243 JOINT WARMTH 1
244 LIP DRY 1
245 LIVER FUNCTION TEST INCREASED 1
246 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
247 LOW DENSITY LIPOPROTEIN INCREASED 1
248 MALIGNANT MELANOMA IN SITU 1
249 MENINGITIS VIRAL 1
250 METASTATIC MALIGNANT MELANOMA 1
251 MIGRAINE 1
252 MOBILITY DECREASED 1
253 MOUTH ULCERATION 1
254 MUSCLE DISORDER 1
255 MUSCULAR WEAKNESS 1
256 MUSCULOSKELETAL DISCOMFORT 1
257 MYELOSUPPRESSION 1
258 NAIL DISORDER 1
259 NASAL CONGESTION 1
260 NASAL DISORDER 1
261 NASAL OEDEMA 1
262 NASOPHARYNGITIS 1
263 NEPHROLITHIASIS 1
264 NERVE INJURY 1
265 NEUTROPENIA 1
266 NODULE 1
267 OCULAR HYPERAEMIA 1
268 OCULAR ICTERUS 1
269 OEDEMA 1
270 OESOPHAGEAL ULCER 1
271 ORGANISING PNEUMONIA 1
272 OSTEOMYELITIS 1
273 OXYGEN SATURATION DECREASED 1
274 PALPITATIONS 1
275 PETECHIAE 1
276 PINGUECULA 1
277 PLASMA CELL MYELOMA 1
278 POOR QUALITY PRODUCT ADMINISTERED 1
279 PRE-EXISTING CONDITION IMPROVED 1
280 PREMATURE AGEING 1
281 PRODUCT ADMINISTRATION INTERRUPTED 1
282 PRODUCT AVAILABILITY ISSUE 1
283 PRODUCT DOSE OMISSION 1
284 PRODUCT STORAGE ERROR 1
285 PRODUCT USE IN UNAPPROVED INDICATION 1
286 PRODUCTIVE COUGH 1
287 PSYCHOTIC DISORDER 1
288 PULMONARY EMBOLISM 1
289 PULMONARY HAEMORRHAGE 1
290 PYOGENIC GRANULOMA 1
291 RALES 1
292 RASH MACULO-PAPULAR 1
293 RASH PRURITIC 1
294 RASH PUSTULAR 1
295 RECTAL HAEMORRHAGE 1
296 RED BLOOD CELL COUNT INCREASED 1
297 RESPIRATORY DISORDER 1
298 RESPIRATORY FAILURE 1
299 RETINAL HAEMORRHAGE 1
300 SCAB 1
301 SCAR 1
302 SCLERODERMA 1
303 SCRATCH 1
304 SEBORRHOEIC DERMATITIS 1
305 SELF-INJURIOUS IDEATION 1
306 SEPSIS 1
307 SKIN ATROPHY 1
308 SKIN CANCER 1
309 SKIN DEPIGMENTATION 1
310 SKIN DISCOMFORT 1
311 SKIN DISORDER 1
312 SKIN HYPOPIGMENTATION 1
313 SKIN MASS 1
314 SKIN PLAQUE 1
315 SKIN REACTION 1
316 SKIN TIGHTNESS 1
317 SKIN WRINKLING 1
318 SLEEP DISORDER 1
319 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
320 SNEEZING 1
321 SOLAR DERMATITIS 1
322 SPINAL DISORDER 1
323 STOMATITIS 1
324 SUICIDAL IDEATION 1
325 TACHYPNOEA 1
326 THERAPEUTIC PRODUCT INEFFECTIVE 1
327 THIRST 1
328 TONGUE ULCERATION 1
329 TRIGGER FINGER 1
330 TYPE 2 DIABETES MELLITUS 1
331 UPPER RESPIRATORY TRACT INFECTION 1
332 URINARY INCONTINENCE 1
333 URINARY RETENTION 1
334 VASCULAR INJURY 1
335 VASCULITIS 1
336 VISION BLURRED 1
337 VITILIGO 1
338 VITREOUS HAEMORRHAGE 1
339 VOMITING 1
340 VON WILLEBRAND^S DISEASE 1
341 WALKING DISABILITY 1
342 WEIGHT INCREASED 1
343 WOUND 1